ARCHIVES

Women’s Health Initiative Trial Produced $37.1 Billion in Returns

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

July 27, 2012

BCDDP “Major Accomplishment” Described By ACS’ Holleb

July 21, 1978

FDA Approves SNDA For Gardasil For Anal Cancer And Precancerous Lesions

January 28, 2011

Reponses To Ford’s Request For Scientific Rational Of Cigarette Regulation Based On Epidemiologic Studies

November 8, 1974

Demonstration project to yield useful data, Peter Bach says.

June 3, 2005

Risk-Benefit Analysis Advised Prior To Hormone Therapy

August 27, 2010